This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

Lou Whiteman

Senior Writer: Transportation

Lou Whiteman has covered transports and the industrials for The Deal for more than a decade, developing an extensive list of contacts including industry leaders, consultants, regulators and labor representatives. Lou has reported on negotiations between major airlines ahead of deal announcements, identified takeout targets in aerospace prior to auctions being made public, participated in briefings with regulators and airline CEOs, and reported on many discussions prior to them becoming public. In earlier assignments for The Deal, Lou focused on technology startups and venture capital.

 

Prior to joining The Deal, Lou covered community and regional banks for American Banker and was also a reporter for the Baltimore Business Journal. Lou has appeared on numerous television and radio outlets, including CNN International, Fox Business News and National Public Radio.

 

Lou has a bachelor’s degree from Loyola University Maryland. Twitter: @louwhiteman

Lou Whiteman
By This Author:
« Back
Page 1 of 16

Three Truckers Set to Drive M&A Activity into High Gear

By Lou Whiteman

With supply and demand moving back into balance and buyers on the prowl, the time is right for would-be sellers to hit the market.

04:10PM 02/26/15

USA Truck Extends Cooperation Agreement With Activist Owners

By Lou Whiteman

The company has agreed to back three activist candidates for reelection to the board as part of a broader deal that would see the firms sell down their holdings.

03:02PM 02/26/15

Bristol-Myers Commits Up to $1.25 Billion to Add Flexus Cancer Therapies

By Lou Whiteman

The pharma giant is making an upfront payment of $800 million and committing to up to $450 million more in milestone payments.

11:14AM 02/23/15

For Manufacturer ITT, It Is Time to Put Its Balance Sheet to Work

By Lou Whiteman

The manufacturer could again be a target for activists if it doesn't find growth, and that could mean a sale of the entire company.

10:31AM 02/20/15

Rite Aid Sees Wider Margins in $2 Billion Envision Deal

By Lou Whiteman

The cash-and-stock acquisition of the TPG Capital-backed pharmacy-benefit manager follows rival CVS' successful purchase of Caremark.

11:03AM 02/11/15

GM Is Caught Between Short-Term Desires, Long-Term Needs

By Lou Whiteman

The automaker's executives are trying to do the right thing by investing in technology and rebuilding a captive finance unit. But investors want a chunk of the company's cash.

04:58PM 02/10/15

Harris in $4.7 Billion Takeover of Rival Pentagon Supplier Exelis

By Lou Whiteman

Both companies have vied in recent years for contracts, including one that Harris won to modernize the air traffic control system.

10:30AM 02/06/15

Nine Defense Contractors That Stand to Win Big With New Budget

By Lou Whiteman

Boeing, Lockheed, ManTech and Esterline rank among the potential beneficiaries as international tensions push up an already robust spending plan proposed by the Obama administration.

11:44AM 02/05/15

Pfizer Gets Growth Injection With $17 Billion Hospira Deal

By Lou Whiteman

The New York-based buyer has been seeking new targets since an unsuccessful $120 billion bid for AstraZeneca.

08:46AM 02/05/15

Staples Puts Pen to Paper on $6.3 Billion Office Depot Bid

By Lou Whiteman

The deal is sure to face antitrust scrutiny, though competition has changed dramatically since the companies' ill-fated merger attempt in 1997.

10:29AM 02/04/15

« Back
Page 1 of 16

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV

Markets

DOW 18,288.63 +155.93 0.86%
S&P 500 2,117.39 +12.89 0.61%
NASDAQ 5,008.0960 +44.5690 0.90%

Brokerage Partners

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs